How to Store GLOW: Temperature, Shelf Life & Handling
Storage requirements for GLOW follow from what the molecule actually is — three-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg (70 mg total). The conditions below reflect that chemistry rather than generic peptide guidance.
In plain English
Freezer for the powder, fridge once mixed, two to three weeks, kept dark. The window is set by the GHK-Cu and TB-500 parts rather than the BPC-157, which on its own would keep longer. Darkness matters here because two of the three ingredients need it.
What GLOW actually is
GLOW is three well-known research compounds freeze-dried together in a single 70 mg vial: GHK-Cu at 50 mg, BPC-157 at 10 mg and TB-500 at 10 mg. Each is studied separately elsewhere, and each works through a different mechanism — collagen and skin matrix for GHK-Cu, blood vessel formation for BPC-157, cell movement for TB-500.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Storage conditions for GLOW
Why these conditions, specifically
Because GHK-Cu dominates, GLOW behaves far more like a copper-peptide preparation than like a generic peptide blend. Apply GHK-Cu handling rules first and the rest follows.
The main route to be aware of: copper dissociation from the GHK-Cu component at acidic pH or on contact with chelators such as EDTA — visible as the blue colour fading, and the single most consequential failure mode given GHK-Cu is 71% of the fill.
All 4 degradation routes for GLOWFreeze–thaw
Aliquot on reconstitution. The three components degrade on independent schedules, so repeated cycles shift the ratio as well as reducing total content.
What GLOW is studied for
The majority component, with the deepest dermal literature — collagen and glycosaminoglycan synthesis in fibroblast models.
Studied around vessel formation and growth-factor pathways in tissue-repair models.
Actin sequestration and directed cell movement — how cells reach a tissue defect.
The three components act through genuinely non-overlapping mechanisms, which is the rationale for combining them.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More GLOW reference
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Storage reference for other compounds
GLOW is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.